Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Bimatoprost (lashes) wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Prescription topical. Bimatoprost 0.03% is applied once daily as a thin line to the skin of the UPPER eyelid margin at the lash base (not to the lower lid, and avoid getting it in the eye), using a fresh applicator per eye. Continuous use is needed to maintain results. Use under a clinician, especially if you have glaucoma or take prostaglandin eye drops. There is no oral or systemic use. This library does not provide an ingestion protocol.
evening
Bimatoprost 0.03% solution (Latisse) with single-use applicators, under a clinician
Topical cosmetic only. Leave-on lactic acid is used at roughly 5-12% (lower for hydration, higher for exfoliation); professional peels use higher strengths. Apply to clean skin, often at night, building frequency as tolerated, with daily sunscreen. There is no oral or systemic dose — it is not ingested. This library does not provide an ingestion protocol.
evening
Leave-on lotion or serum (≈5-12% lactic acid)
Throughout
8-16 weeks
2-6 months after stopping
Weeks to months
Throughout
2-8 weeks
8-22 weeks
Throughout
Long-term safety and efficacy of bimatoprost solution 0.03% application to the eyelid margin for the treatment of idiopathic and chemotherapy-induced eyelash hypotrichosis: a randomized controlled trial.
Br J Dermatol (2015) · Rct
1-year double-masked RCT: composite primary endpoint (Global Eyelash Assessment + satisfaction) met for bimatoprost vs vehicle in idiopathic (40.2% vs 6.8%) and post-chemotherapy (37.5% vs 18.2%) hypotrichosis
Bimatoprost for eyelash growth in Japanese subjects: two multicenter controlled studies.
Aesthetic Plast Surg (2014) · Rct · n=209
Two double-masked vehicle-controlled RCTs (n=209: 173 idiopathic, 36 chemotherapy-induced) in Japanese subjects
The efficacy of topical prostaglandin analogs for hair loss: A systematic review and meta-analysis.
Front Med (Lausanne) (2023) · Meta analysis
Meta-analysis of six placebo-controlled RCTs of topical prostaglandin analogs (incl. bimatoprost) for hair growth (lashes, brows, scalp)
Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial.
Arch Dermatol (1996) · Rct · n=74
22-week double-blind vehicle-controlled trial (n=74): 8% L-lactic acid cream twice daily improved facial photodamage in 71% vs 40% with vehicle (P<.05)
Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function.
Arch Dermatol Res (1996) · In vitro
Lactic acid stimulated keratinocyte ceramide biosynthesis in vitro, L-isomer far more potent (300% vs 100%)
Applications of hydroxy acids: classification, mechanisms, and photoactivity.
Clin Cosmet Investig Dermatol (2010) · Review
FDA/NIH review of alpha-, beta-, poly-, and bionic hydroxy acids across photoaging, pigmentation, acne, and ichthyosis
Bimatoprost (lashes) has a higher evidence score (8/10 vs 6/10) and wins in 2 of 3 categories.
No known interactions between Bimatoprost (lashes) and Lactic Acid (topical) have been documented in our database. However, always consult a healthcare provider before combining supplements.